Previous article
Fidaxomicin vs Vancomycin for Clostridioides difficile Infection
Jun 2025
Next article
Educational Interventions Improve Adverse Drug Reaction Reporting
Cochrane for Clinicians

Blood Pressure Targets for Hypertension in People With Chronic Kidney Disease

Tara Devaraj, MD,
Karl T. Clebak, MD, MHA, FAAFP,
Zakary S. Newberry, MD,
Penn State Health Hershey Medical Center, Hershey

American Family Physician. 2025;111(6):495-496.

Author disclosure: No relevant financial relationships.

This clinical content conforms to AAFP criteria for CME.

Author disclosure: No relevant financial relationships.

  1. 1.Erviti J, Saiz LC, Leache L, et al. Blood pressure targets for hypertension in people with chronic renal disease. Cochrane Database Syst Rev. 2024(10):CD008564.
  2. 2.Centers for Disease Control and Prevention. Chronic kidney disease in the United States, 2023. US Dept of Health and Human Services, CDC; 2023.
  3. 3.Cheung AK, Chang TI, Cushman WC, et al. Executive summary of the KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int. 2021;99(3):559-569.
  4. 4.Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018;71(19):e127-e248.
  5. 5.James PA, Oparil S, Carter BL, et al. 2014 Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507-520.
  6. 6.Mancia G, Kreutz R, Brunström M, et al. 2023 ESH guidelines for the management of arterial hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension: endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens. 2023;41(12):1871-2071.
  7. 7.National Institute for Health and Care Excellence. Chronic kidney disease: assessment and management. NICE guideline 203. NICE; 2021.

These are summaries of reviews from the Cochrane Library.

This series is coordinated by Corey D. Fogleman, MD, assistant medical editor.

A collection of Cochrane for Clinicians published in AFP is available at https://www.aafp.org/afp/cochrane.

Previous article
Fidaxomicin vs Vancomycin for Clostridioides difficile Infection
Jun 2025
Next article
Educational Interventions Improve Adverse Drug Reaction Reporting

Current issue

May 2026

May 2026

Copyright © 2026 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. See permissions for copyright questions and/or permission requests.